Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-10

Clinical Trial Update: A Study of Long-Term Rituximab (MabThera) Maintenance Therapy in Participants With Advanced Follicular Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating long-term rituximab maintenance therapy in participants with advanced follicular lymphoma, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rituximab (MabThera) (Rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Lymphoma, Follicular | Phase 3 | Status: COMPLETED | Results posted: 2015-12-10